Xencor (XNCR) EBIT Margin (QoQ) (2013 - 2026)
Xencor (XNCR) EBIT Margin (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -153,422.00 |
| Dec 31, 2025 | 3,637.00 |
| Sep 30, 2025 | -15,022.00 |
| Jun 30, 2025 | 5,586.00 |
| Mar 31, 2025 | -10,697.00 |
| Dec 31, 2024 | 28,520.00 |
| Sep 30, 2024 | -7,856.00 |
| Jun 30, 2024 | 11,010.00 |
| Mar 31, 2024 | -28,809.00 |
| Dec 31, 2023 | -2,275.00 |
| Sep 30, 2023 | 2,627.00 |
| Jun 30, 2023 | 26,257.00 |
| Mar 31, 2023 | -12,261.00 |
| Dec 31, 2022 | -5,662.00 |
| Sep 30, 2022 | -4,776.00 |
| Jun 30, 2022 | -12,367.00 |
| Mar 31, 2022 | -2,855.00 |
| Dec 31, 2021 | 26,934.00 |
| Sep 30, 2021 | -22,330.00 |
| Jun 30, 2021 | 5,957.00 |